Randomized controlled trial of Sajabalssuk (Artemisia princeps Pampanini) to treat pre-diabetes

European Journal of Integrative Medicine

Volumn 4, Issue 3, 2012, Pages

  Cho, Yun Young ^a   Baek, Nam In ^b   Chung, Hae Gon ^c   Jeong, Tae Sook ^d   Lee, Kyung Tae ^b   Jeon, Seon Min ^a   Kim, Hye Jin ^e   McGregor, Robin A ^a   Choi, Myung Sook ^a  

^a Kyungpook National University   (South Korea)

^b Kyung Hee University   (South Korea)

^c GangHwa Agricultural R and D Center   (South Korea)

^d Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^e CJ Corporation   (South Korea)

Author keywords

Artemisia princeps Pampanini; Fasting blood glucose; HbA1c; HOMA IR; Pinitol; Randomized controlled trial

Indexed keywords

ANTIDIABETIC AGENT; ARTEMISIA PRINCEPS EXTRACT; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; PINITOL; PLACEBO; PLANT EXTRACT; UNCLASSIFIED DRUG;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTEMISIA; ARTEMISIA PRINCEPS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY COMPOSITION; CONTROLLED STUDY; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

EID: 84867141331     PISSN: 18763820     EISSN: 18763839     Source Type: Journal    
DOI: 10.1016/j.eujim.2012.01.009     Document Type: Article

References (33)

1. Roglic G., Unwin N. Mortality attributable to diabetes: estimates for the year 2010. Diabetes Res Clin Pract 2010, 87:15-19.
2. Nolan C.J., Damm P., Prentki M. Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet 2011, 378:169-181.
3. Ackermann R.T., Cheng Y.J., Williamson D.F., Gregg E.W. Identifying adults at high risk for diabetes and cardiovascular disease using hemoglobin A1c: National Health and Nutrition Examination Survey 2005-2006. Am J Prev Med 2011, 40:11-17.
4. Ford E.S., Zhao G., Li C. Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence. J Am Coll Cardiol 2010, 55:1310-1317.
5. Bennett W.L., Maruthur N.M., Singh S., Segal J.B., Wilson L.M., Chatterjee R., et al. Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations. Ann Intern Med 2011, 154:602-613.
6. WHO expert consultation. WHO traditional medicine strategy 2002-2005. Geneva: World Health Organization; 2002.
7. Grant S.J., Bensoussan A., Chang D., Kiat H., Klupp N.L., Liu J.P., et al. Chinese herbal medicines for people with impaired glucose tolerance or impaired fasting blood glucose. Cochrane Database Syst Rev 2009, 4. CD006690.
8. Liu J.P., Wang W., Grimsgaard S. Chinese herbal medicines for type 2 diabetes mellitus. Cochrane Database Syst Rev 2002, 3. CD003642.
9. Qi L.-W., Liu E.-H., Chu C., Peng Y.-B., Cai H.-X., Li P. Anti-diabetic agents from natural products-an update from 2004 to 2009. Curr Top Med Chem 2010, 10:434-457.
10. Han J.-M., Kim M.-J., Baek S.-H., An S., Jin Y.-Y., Chung H.-G., et al. Antiatherosclerotic effects of Artemisia princeps Pampanini cv. Sajabal in LDL receptor deficient mice. J Agric Food Chem 2009, 57:1267-1274.
11. Min S.-W., Kim N.-J., Baek N.-I., Kim D.-H. Inhibitory effect of eupatilin and jaceosidin isolated from Artemisia princeps on carrageenan-induced inflammation in mice. J Ethnopharmacol 2009, 125:497-500.
12. Kim M.-J., Han J.-M., Jin Y.-Y., Baek N.-I., Bang M.-H., Chung H.-G., et al. In vitro antioxidant and anti-inflammatory activities of Jaceosidin from Artemisia princeps Pampanini cv. Sajabal Arch Pharm Res 2008, 31:429-437.
13. Yamamoto N., Kanemoto Y., Ueda M., Kawasaki K., Fukuda I., Ashida H. Anti-obesity and anti-diabetic effects of ethanol extract of Artemisia princeps in C57BL/6 mice fed a high-fat diet. Food Funct 2011, 2:45-52.
14. Kang Y.-J., Jung U.J., Lee M.-K., Kim H.-J., Jeon S.-M., Park Y.B., et al. Eupatilin, isolated from Artemisia princeps Pampanini, enhances hepatic glucose metabolism and pancreatic beta-cell function in type 2 diabetic mice. Diabetes Res Clin Pract 2008, 82:25-32.
15. Jung U.J., Baek N.-I., Chung H.-G., Jeong T.-S., Lee K.T., Lee M.-K., et al. Antilipogenic and hypolipidemic effects of ethanol extracts from two variants of Artemisia princeps Pampanini in obese diabetic mice. J Med Food 2009, 12:1238-1244.
16. Jung U.J., Baek N.-I., Chung H.-G., Bang M.-H., Yoo J.-S., Jeong T.S., et al. The anti-diabetic effects of ethanol extract from two variants of Artemisia princeps Pampanini in C57BL/KsJ-db/db mice. Food Chem Toxicol 2007, 45:2022-2029.
17. Yamamoto N., Ueda M., Kawabata K., Sato T., Kawasaki K., Hashimoto T., et al. Artemisia princeps extract promoted glucose uptake in cultured L6 muscle cells via glucose transporter 4 translocation. Biosci Biotechnol Biochem 2010, 74:2036-2042.
18. Chang S.H., Jung E.J., Park Y.H., Lim D.G., Ko N.Y., Choi W.S., et al. Anti-inflammatory effects of Artemisia princeps in antigen-stimulated T cells and regulatory T cells. J Pharm Pharmacol 2009, 61:1043-1050.
19. Choi J.-Y., Shin S.-K., Jeon S.-M., Baek N.-I., Chung H.-G., Jeong T.-S., et al. Dose-response study of Sajabalssuk ethanol extract from Artemisia princeps Pampanini on blood glucose in subjects with impaired fasting glucose or mild type 2 diabetes. J Med Food 2011, 14:101-107.
20. Diagnosis A.D.A. Classification of diabetes mellitus. Diabetes Care 2010, 33:S62-S69.
21. Kang M.-J., Kim J.-I., Yoon S.-Y., Kim J.C., Cha I.-J. Pinitol from soybeans reduces postprandial blood glucose in patients with type 2 diabetes mellitus. J Med Food 2006, 9:182-186.
22. Davis A., Christiansen M., Horowitz J.F., Klein S., Hellerstein M.K., Ostlund R.E. Effect of pinitol treatment on insulin action in subjects with insulin resistance. Diabetes Care 2000, 23:1000-1005.
23. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
24. Currie C.J., Peters J.R., Tynan A., Evans M., Heine R.J., Bracco O.L., et al. Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study. Lancet 2010, 375:481-489.
25. Moller D.E. New drug targets for type 2 diabetes and the metabolic syndrome. Nature 2001, 414:821-827.
26. Grundy S.M., Cleeman J.I., Bairey Merz C.N., Brewer H.B., Clark L.T., Hunninghake D.B., et al. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. J Am Coll Cardiol 2004, 44:720-732.
27. Henry P., Thomas F., Benetos A., Guize L. Impaired fasting glucose, blood pressure and cardiovascular disease mortality. Hypertension 2002, 40:458-463.
28. WHO Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004, 363:157-163.
29. Kim M.-J., Kim D.-H., Lee K.W., Yoon D.-Y., Surh Y.-J. Jaceosidin induces apoptosis in ras-transformed human breast epithelial cells through generation of reactive oxygen species. Ann N Y Acad Sci 2007, 1095:483-495.
30. Choi E.-J., Oh H.-M., Wee H., Choi C.-S., Choi S.-C., Kim K.-H., et al. Eupatilin exhibits a novel anti-tumor activity through the induction of cell cycle arrest and differentiation of gastric carcinoma AGS cells. Differentiation 2009, 77:412-423.
31. Cho J.-H., Lee J.-G., Yang Y.-I., Kim J.-H., Ahn J.-H., Baek N.-I., et al. Eupatilin, a dietary flavonoid, induces G2/M cell cycle arrest in human endometrial cancer cells. Food Chem Toxicol 2011, 49:1737-1744.
32. Hopper I., Billah B., Skiba M., Krum H. Prevention of diabetes and reduction in major cardiovascular events in studies of subjects with prediabetes: meta-analysis of randomised controlled clinical trials. Eur J Cardiovasc Prev Rehabil 2011, 10.1177/1741826711421687.
33. Pulido J.M.E., Salazar M.A. Changes in insulin sensitivity, secretion and glucose effectiveness during menstrual cycle. Arch Med Res 1999, 30:19-22.